
Eli Lilly and Co
NYSE:LLY

Intrinsic Value
The intrinsic value of one
LLY
stock under the Base Case scenario is
374.63
USD.
Compared to the current market price of 839.96 USD,
Eli Lilly and Co
is
Overvalued by 55%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Eli Lilly and Co
Fundamental Analysis

Despite the significant buzz around tirzepatide and other diabetes products, their high development and marketing costs could erode profitability if insurance reimbursement or pricing pressures intensify, particularly in today’s cost-conscious healthcare environment.
Tirzepatide’s rapid approvals and robust clinical outcomes in diabetes and obesity treatments position Eli Lilly to capture valuable market share in a high-growth therapeutic area, protecting long-term revenue streams.

Revenue & Expenses Breakdown
Eli Lilly and Co
Balance Sheet Decomposition
Eli Lilly and Co
Current Assets | 32.7B |
Cash & Short-Term Investments | 3.4B |
Receivables | 13.3B |
Other Current Assets | 16B |
Non-Current Assets | 46B |
Long-Term Investments | 3.2B |
PP&E | 17.1B |
Intangibles | 11.9B |
Other Non-Current Assets | 13.7B |
Free Cash Flow Analysis
Eli Lilly and Co
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Eli Lilly and Co
Revenue
|
45B
USD
|
Cost of Revenue
|
-8.4B
USD
|
Gross Profit
|
36.6B
USD
|
Operating Expenses
|
-19.6B
USD
|
Operating Income
|
17B
USD
|
Other Expenses
|
-6.5B
USD
|
Net Income
|
10.6B
USD
|
LLY Profitability Score
Profitability Due Diligence
Eli Lilly and Co's profitability score is 75/100. The higher the profitability score, the more profitable the company is.

Score
Eli Lilly and Co's profitability score is 75/100. The higher the profitability score, the more profitable the company is.
LLY Solvency Score
Solvency Due Diligence
Eli Lilly and Co's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Score
Eli Lilly and Co's solvency score is 65/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
LLY Price Targets Summary
Eli Lilly and Co
According to Wall Street analysts, the average 1-year price target for
LLY
is 1 043.17 USD
with a low forecast of 808 USD and a high forecast of 1 249.5 USD.
Dividends
Current shareholder yield for LLY is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
LLY
stock under the Base Case scenario is
374.63
USD.
Compared to the current market price of 839.96 USD,
Eli Lilly and Co
is
Overvalued by 55%.